GSK Gets Top Court Assist In MDL Victory 'Roadmap'
By Chris Villani · June 18, 2021, 3:45 PM EDT
A sweeping order ending more than 400 cases alleging GlaxoSmithKline's anti-nausea medication Zofran causes birth defects provides a "roadmap" for fending off multidistrict litigation with the help of a landmark U.S....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login